Unknown

Dataset Information

Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G.


ABSTRACT: Strategies to control HIV-1 replication without antiviral therapy are needed to achieve a functional cure. To exploit the innate antiviral function of restriction factor cytidine deaminase APOBEC3G (A3G), we developed self-activating lentiviral vectors that efficiently deliver HIV-1 Vif-resistant mutant A3G-D128K to target cells. To circumvent APOBEC3 expression in virus-producing cells, which diminishes virus infectivity, a vector containing two overlapping fragments of A3G-D128K was designed that maintained the gene in an inactive form in the virus-producer cells. However, during transduction of target cells, retroviral recombination between the direct repeats reconstituted an active A3G-D128K in 89%-98% of transduced cells. Lentiviral vectors that expressed A3G-D128K transduced CD34

SUBMITTER: Delviks-Frankenberry KA 

PROVIDER: S-EPMC6889484 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature